Inovio Pharmaceuticals Inc vs VF Corp — how do they compare? Inovio Pharmaceuticals Inc trades at $1.08 (market cap $89.27M), while VF Corp trades at $16.88 (market cap $6.62B). The key difference: VF Corp is far larger — about 74.2× Inovio Pharmaceuticals Inc's market cap, and VF Corp pays a 2.13% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| INO | VFC | |
|---|---|---|
Market Cap | $89.27M | $6.62B |
Sector | Health | Consumer Cyclical |
52-Week High | $2.87 | $21.55 |
52-Week Low | $1.05 | $11.66 |
Enterprise Value | $60.28M | $10.77B |
Dividend Yield | — | 2.13% |
Trailing returns across standard periods
Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.
Read more on INO →VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.
Read more on VFC →